J. van de Loo

495 total citations
33 papers, 332 citations indexed

About

J. van de Loo is a scholar working on Hematology, Oncology and Surgery. According to data from OpenAlex, J. van de Loo has authored 33 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 7 papers in Oncology and 6 papers in Surgery. Recurrent topics in J. van de Loo's work include Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Neutropenia and Cancer Infections (4 papers). J. van de Loo is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Neutropenia and Cancer Infections (4 papers). J. van de Loo collaborates with scholars based in Germany, Malaysia and Indonesia. J. van de Loo's co-authors include Wolfgang Hiddemann, M. Essink, Thomas Büchner, Th. Büchner, F. Praetorius, R Schmutzler, H. Poliwoda, Christian H. Ottensmeier, Mathias Freund and N. Roos and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Journal of Molecular Medicine.

In The Last Decade

J. van de Loo

29 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. van de Loo Germany 8 78 73 70 70 63 33 332
Marjolein L. Donker Netherlands 7 41 0.5× 70 1.0× 55 0.8× 120 1.7× 20 0.3× 9 409
Andreu Llorente Spain 11 14 0.2× 53 0.7× 85 1.2× 163 2.3× 41 0.7× 20 491
SJ Slichter United States 9 26 0.3× 77 1.1× 81 1.2× 453 6.5× 47 0.7× 16 664
P. Cervi United Kingdom 8 19 0.2× 89 1.2× 106 1.5× 62 0.9× 11 0.2× 15 339
Øystein Wendelbo Norway 12 32 0.4× 22 0.3× 93 1.3× 93 1.3× 45 0.7× 37 409
Edward G. Wyshock United States 8 24 0.3× 202 2.8× 16 0.2× 256 3.7× 29 0.5× 9 421
Knut Anders Mosevoll Norway 13 29 0.4× 31 0.4× 90 1.3× 159 2.3× 48 0.8× 25 456
M. Kerowgan Germany 10 12 0.2× 61 0.8× 25 0.4× 200 2.9× 50 0.8× 16 359
Sílvia Pérez‐Pujol Spain 11 34 0.4× 19 0.3× 31 0.4× 198 2.8× 43 0.7× 18 429
Neerja Agrawal United States 8 16 0.2× 19 0.3× 70 1.0× 42 0.6× 64 1.0× 19 409

Countries citing papers authored by J. van de Loo

Since Specialization
Citations

This map shows the geographic impact of J. van de Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. van de Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. van de Loo more than expected).

Fields of papers citing papers by J. van de Loo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. van de Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. van de Loo. The network helps show where J. van de Loo may publish in the future.

Co-authorship network of co-authors of J. van de Loo

This figure shows the co-authorship network connecting the top 25 collaborators of J. van de Loo. A scholar is included among the top collaborators of J. van de Loo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. van de Loo. J. van de Loo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conklin, Laurie S., J. van de Loo, Sema Mandal, et al.. (2013). Investigation of a Chlamydia pneumoniae Outbreak in a Federal Correctional Facility in Texas. Clinical Infectious Diseases. 57(5). 639–647. 19 indexed citations
2.
Thomas, Michael, et al.. (2008). Erfolgreiche multimodale Behandlung eines lokal weit fortgeschrittenen nichtkleinzelligen Bronchialkarzinoms. DMW - Deutsche Medizinische Wochenschrift. 121(20). 658–662.
3.
Berdel, Wolfgang E., Th. Büchner, Joachim Kienast, & J. van de Loo. (2000). Transplantation in Hematology and Oncology. 1 indexed citations
4.
Schumacher, Andrea, Torsten Keßler, A. Riedel, Thomas Büchner, & J. van de Loo. (1996). [Quality of life and coping with illness in patients with acute myeloid leukemia].. PubMed. 46(11). 385–90. 4 indexed citations
5.
Kusnierz-Glaz, C., Rona Singer Weinberg, Roland J. Fuchs, et al.. (1993). Subcutaneous low dose arabinosyl‐cytosine and oral idarubicin in high risk adult acute myelogenous leukemia. Hematological Oncology. 11(2). 73–80. 6 indexed citations
6.
Hiddemann, Wolfgang, et al.. (1992). Interleukin-2 followed by fluorouracil and folinic acid in refractory colorectal cancer--results of a clinical phase II study.. PubMed. 19(2 Suppl 3). 225–7. 4 indexed citations
7.
Hiddemann, Wolfgang, B. Wörmann, A. Thiel, et al.. (1991). Treatment of advanced chronic lymphocytic leukemia by fludarabine. Annals of Hematology. 63(1). 1–4. 65 indexed citations
8.
Loo, J. van de, et al.. (1991). Hämostasefaktoren und koronare Herzkrankheit. Hämostaseologie. 11(4). 172–188. 3 indexed citations
9.
Eiff, M. von, M. Essink, N. Roos, et al.. (1990). Hepatosplenic candidiasis, a late manifestation of Candida septicaemia in neutropenic patients with haematologic malignancies. Annals of Hematology. 60(4). 242–248. 41 indexed citations
10.
Stenzinger, W., et al.. (1990). Treatment of refractory multiple myeloma with the vincristine-adriamycin-dexamethasone (VAD) regimen. Annals of Hematology. 61(2-3). 55–59. 4 indexed citations
11.
Kusnierz-Glaz, C., et al.. (1990). Magnetic Resonance Imaging Follow-up in Patients with Acute Leukemia During Induction Chemotherapy. Hämatologie und Bluttransfusion. 33. 351–356. 2 indexed citations
12.
Kienast, Joachim, Helmut Ostermann, W. Stenzinger, Elmar Kotter, & J. van de Loo. (1989). Anti-Phospholipid Antikörper mit rezidivierenden venösen Thromboembolien und schwerer Autoimmunthrombozytopenie. Journal of Molecular Medicine. 67(13). 691–695. 1 indexed citations
13.
Preusser, P., H. Wilke, W. Achterrath, et al.. (1988). Phase-II-Study with EAP (Etoposide, Adriamycin, Cis- Platinum) in Patients with Primary Inoperable Gastric Cancer and Advanced Disease. Recent results in cancer research. 110. 198–206. 5 indexed citations
14.
Volkenandt, Matthias, Thomas Büchner, Wolfgang Hiddemann, & J. van de Loo. (1987). ACUTE LEUKAEMIA DURING PREGNANCY. The Lancet. 330(8574). 1521–1522. 18 indexed citations
15.
Urbanitz, D., et al.. (1986). Lysostaphin-based assay of human granulocyte functions: A reevaluation. Journal of Molecular Medicine. 64(20). 1029–1035. 1 indexed citations
16.
Büchner, Th., et al.. (1983). Die Studie Münster über intensivierte Induktions- und Konsolidierungstherapie ohne Erhaltungstherapie der AML. Oncology Research and Treatment. 6(4). 176–178. 1 indexed citations
17.
Urbanitz, D., et al.. (1981). Intensified remission induction therapy for acute nonlymphocytic leukemia (ANLL) treatment report on 60 patients. Annals of Hematology. 43(2). 129–133. 2 indexed citations
18.
Urbanitz, D., Wolfgang Hiddemann, Leopold Balleisen, et al.. (1979). Intensification of remission induction therapy for acute nonlymphocytic leukemia (ANLL). Annals of Hematology. 39(2). 133–140. 6 indexed citations
19.
Loo, J. van de & Marc Verstraete. (1974). Fibrinolytic treatment of acute myocardial infarction: a question still open. 1 indexed citations
20.
Asbeck, F, et al.. (1972). The Mechanism of Intravascular Activation of the Fibrinolytic System during Hormonal Contraception. Pathophysiology of Haemostasis and Thrombosis. 1(2). 108–119. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marjolein L. Donker Breakdown of academic impact, for papers by Andreu Llorente Breakdown of academic impact, for papers by SJ Slichter Breakdown of academic impact, for papers by P. Cervi Breakdown of academic impact, for papers by Øystein Wendelbo Breakdown of academic impact, for papers by Edward G. Wyshock Breakdown of academic impact, for papers by Knut Anders Mosevoll Breakdown of academic impact, for papers by M. Kerowgan Breakdown of academic impact, for papers by Sílvia Pérez‐Pujol Breakdown of academic impact, for papers by Neerja Agrawal
Rankless by CCL
2026